Nureca Ltd

Nureca Ltd share price ticked higher by 4.69% to Rs 332.8 after the company's net profit soared by 31.92% to Rs 4.05 crore, while revenue from operations increased sharply by 45.09% to Rs 58.53 crore in Q3FY26 over Q2FY26. The market capitalization of Medical Equipment & Supplies industry group stocks on BSE stood at Rs 24205.38 crore, declining 6.23%. It has slipped by 7.35% over last one week and surged by 51.56% in last one month while the market capitalization of Nureca Ltd has improved by 2.75% and 10.66% in the same period respectively. Profit before tax (PBT) of Nureca Ltd stood at Rs 5.52 crore in Q3 FY26, jumping 20.00% year-on-year, and surging by 24.60% quarter-on-quarter. EBITDA came in at Rs 4 crore, expanding by 304.17% YoY and rallying 142.50% sequentially. Total expenses jumped by 44.15% to Rs 54.1 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 6.14 crore, soaring by 23.79% YoY, while employee benefits expense was at Rs 4.11 crore, falling 7.22% YoY. For the TTM ended FY26, revenue from operations surged 34.01% to Rs 146.96 crore, while net profit jumped 144.71% to Rs 2.08 crore, compared to previous TTM. EBITDA saw a sharp decline of 2130% to Rs 7.92 crore, and PBT witnessed a strong rise of 271.64% to Rs 4.98 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 3.3 crore in FY26, as against Rs 19.08 crore in FY25. Nureca Ltd gained 4.33% in last one year, significantly outperforming the benchmark BSE Sensex which has declined by 12.69% during the same period.

Nureca Ltd share price declined by 2.93% to Rs 317.9. The Company's net profit jumped 31.92% to Rs 4.05 crore, while revenue from operations increased sharply by 45.09% to Rs 58.53 crore in Q3FY26 over Q2FY26. The market capitalization of Medical Equipment & Supplies industry group stocks on BSE stood at Rs 23909.73 crore, declining 6.23%. It has softened by 2.18% over last one week and jumped by 64.34% in last one month while the market capitalization of Nureca Ltd has eased by 2.45% and 7.16% in the same period respectively. Profit before tax (PBT) of Nureca Ltd stood at Rs 5.52 crore in Q3 FY26, rallying 20.00% year-on-year, and expanding by 24.60% quarter-on-quarter. EBITDA came in at Rs 4 crore, jumping 304.17% YoY and surging by 142.50% sequentially. Total expenses witnessed a sharp rise of 44.15% to Rs 54.1 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 6.14 crore, witnessing a sharp rise of 23.79% YoY, while employee benefits expense was at Rs 4.11 crore, falling 7.22% YoY. For the TTM ended FY26, revenue from operations surged 34.01% to Rs 146.96 crore, while net profit soared by 144.71% to Rs 2.08 crore, compared to previous TTM. EBITDA tumbled by 2130% to Rs 7.92 crore, and PBT soared 271.64% to Rs 4.98 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 3.3 crore in FY26, as against Rs 19.08 crore in FY25. Nureca Ltd fell 5.57% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 12.46% during the same period.

Nureca Limited submitted a certificate to the BSE Limited and National Stock Exchange of India Limited under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, as confirmed by its Registrar and Share Transfer Agent, Alankit Assignments Limited.

Nureca Limited will hold a board meeting on Wednesday, October 21, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2026, as announced to the BSE Limited and National Stock Exchange of India Limited.

Nureca Limited informed the BSE Limited and National Stock Exchange of India Limited that the trading window for dealing in the company's equity shares will be closed from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the second quarter and half-year ending September 30, 2026, prohibiting trading for designated persons and their immediate relatives.

Net profit of Nureca rose 279.01% to Rs 3.07 crore in the quarter ended June 2026 as against Rs 0.81 crore during the previous quarter ended June 2025. Sales rose 18.02% to Rs 40.34 crore in the quarter ended June 2026 as against Rs 34.18 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales40.3434.18 18 OPM %8.48-1.64 - PBDT5.041.76 186 PBT4.431.23 260 NP3.070.81 279 Powered by Capital Market - Live

Nureca will hold a meeting of the Board of Directors of the Company on 21 July 2026.

Hinduja Global Solutions Ltd, Wanbury Ltd, Fino Payments Bank Ltd and Orient Technologies Ltd are among the other gainers in the BSE's 'B' group today, 14 July 2026.Nureca Ltd surged 13.94% to Rs 280.3 at 12:01 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 21770 shares were traded on the counter so far as against the average daily volumes of 1218 shares in the past one month. Hinduja Global Solutions Ltd soared 12.99% to Rs 471.05. The stock was the second biggest gainer in 'B' group. On the BSE, 28493 shares were traded on the counter so far as against the average daily volumes of 10936 shares in the past one month. Wanbury Ltd spiked 12.62% to Rs 338.7. The stock was the third biggest gainer in 'B' group. On the BSE, 2.14 lakh shares were traded on the counter so far as against the average daily volumes of 12946 shares in the past one month. Fino Payments Bank Ltd jumped 11.61% to Rs 179.7. The stock was the fourth biggest gainer in 'B' group. On the BSE, 19.54 lakh shares were traded on the counter so far as against the average daily volumes of 98421 shares in the past one month. Orient Technologies Ltd advanced 11.54% to Rs 288.95. The stock was the fifth biggest gainer in 'B' group. On the BSE, 2.63 lakh shares were traded on the counter so far as against the average daily volumes of 18896 shares in the past one month. Powered by Capital Market - Live

Nureca announced that the 10th Annual General Meeting(AGM) of the company will be held on 28 July 2026.

Net loss of Nureca reported to Rs 6.09 crore in the quarter ended March 2026 as against net profit of Rs 2.47 crore during the previous quarter ended March 2025. Sales rose 11.56% to Rs 35.41 crore in the quarter ended March 2026 as against Rs 31.74 crore during the previous quarter ended March 2025. For the full year,net profit rose 144.71% to Rs 2.08 crore in the year ended March 2026 as against Rs 0.85 crore during the previous year ended March 2025. Sales rose 34.01% to Rs 146.96 crore in the year ended March 2026 as against Rs 109.66 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales35.4131.74 12 146.96109.66 34 OPM %-16.323.78 -0.12-6.88 - PBDT-5.062.57 PL 7.003.68 90 PBT-5.512.05 PL 4.981.34 272 NP-6.092.47 PL 2.080.85 145 Powered by Capital Market - Live